Hypoxia is a ubiquitous negative prognostic factor in solid tumours. Oxygen-enhanced MRI can spatially map regions refractory to an oxygen challenge and, when combined with a perfusion measurement, has the potential to quantify hypoxia in vivo. We developed the technique in healthy volunteers before successfully translating into a longitudinal patient study of patients with cervical carcinoma. We present initial data to support OE-MRI quantifying and mapping hypoxia modification following therapy in this clinical dataset.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords